A PRELIMINARY TRIAL OF THE PROGRAMMABLE IMPLANTABLE MEDICATION SYSTEM FOR INSULIN DELIVERY

被引:113
作者
SAUDEK, CD
SELAM, JL
PITT, HA
WAXMAN, K
RUBIO, M
JEANDIDIER, N
TURNER, D
FISCHELL, RE
CHARLES, MA
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT SURG, BALTIMORE, MD 21205 USA
[2] UNIV CALIF IRVINE, DEPT MED, IRVINE, CA 92717 USA
[3] UNIV CALIF IRVINE, DEPT SURG, IRVINE, CA 92717 USA
[4] JOHNS HOPKINS UNIV, APPL PHYS LAB, LAUREL, MD 20707 USA
关键词
D O I
10.1056/NEJM198908313210904
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:574 / 579
页数:6
相关论文
共 32 条
[1]  
ALBISSER AM, 1980, DIABETES, V29, P241, DOI 10.2337/diabetes.29.3.241
[2]  
BLACKSHEAR PJ, 1979, MED PROG TECHNOL, V6, P149
[3]   GLYCEROL PREVENTS INSULIN PRECIPITATION AND INTERRUPTION OF FLOW IN AN IMPLANTABLE INSULIN INFUSION PUMP [J].
BLACKSHEAR, PJ ;
ROHDE, TD ;
PALMER, JL ;
WIGNESS, BD ;
RUPP, WM ;
BUCHWALD, H .
DIABETES CARE, 1983, 6 (04) :387-392
[4]   METABOLIC RESPONSE TO 3 YEARS OF CONTINUOUS, BASAL RATE INTRAVENOUS INSULIN INFUSION IN TYPE-II DIABETIC-PATIENTS [J].
BLACKSHEAR, PJ ;
SHULMAN, GI ;
ROUSSELL, AM ;
NATHAN, DM ;
MINAKER, KL ;
ROWE, JW ;
ROBBINS, DC ;
COHEN, AM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (04) :753-760
[5]  
BUCHWALD H, 1981, LANCET, V1, P1233
[6]  
BUCHWALD J, 1984, IMPLANTABLE INSULIN, P177
[7]  
BUNN HF, 1979, J BIOL CHEM, V254, P3892
[8]   EFFECT OF NEAR NORMOGLYCEMIA FOR 2 YEARS ON PROGRESSION OF EARLY DIABETIC-RETINOPATHY, NEPHROPATHY, AND NEUROPATHY - THE OSLO STUDY [J].
DAHLJORGENSEN, K ;
BRINCHMANNHANSEN, O ;
HANSSEN, KF ;
GANES, T ;
KIERULF, P ;
SMELAND, E ;
SANDVIK, L ;
AAGENAES, O .
BRITISH MEDICAL JOURNAL, 1986, 293 (6556) :1195-1199
[9]  
DCCT Res Grp, 1986, DIABETES, V35, P530
[10]  
DCCT Res Grp, 1987, DIABETES CARE, V10, P1